Karolini Zuqui Nunes

Karolini Zuqui Nunes

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Revista Latino-Americana de Enfermagem
Verified
Journal Article
Open access
PDF file
Luís Carlos Lopes-JúniorLuís Carlos Lopes-Júnior
Luís Carlos Lopes-Júnior
GRGabriela Sylvestre Rosa
Gabriela Sylvestre Rosa
RPRaphael Manhaes Pessanha
Raphael Manhaes Pessanha
SSSara Isabel Pimentel De Carvalho Schuab
Sara Isabel Pimentel De Carvalho Schuab
KNKarolini Zuqui Nunes
Karolini Zuqui Nunes
MAMaria Helena Costa Amorim
Maria Helena Costa Amorim
Objective: to synthesize the knowledge and to critically evaluate the evidences arising from randomized controlled trials on the efficacy of the complementary therapies in the management of cancer pain in adult patients with cancer in palliative care. Method: a systematic review guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The search for articles in the MEDLINE, ISI Web of Knowledge, CENTRAL Cochrane, and PsycINFO databases, as well as the manual search, selection of studies, data extraction, and methodological assessment using the Cochrane Bias Risk tool were performed independently by two reviewers. Results: eight hundred and fifteen (815) studies were identified, six of them being selected and analyzed, of which three used massage therapy, one study used a combination of progressive muscle relaxation and guided imaging, and another two studies used acupuncture. Most of the studies had an uncertain risk of bias (n=4; 67%). Conclusion: while the evidence from the studies evaluating the use of massage therapy or the use of progressive muscle relaxation and guided imaging for the management of cancer pain in these patients demonstrated significant benefits, the other two studies that evaluated the use of acupuncture as a complementary therapy showed contradictory results, therefore, needing more research studies to elucidate such findings.

Luís Carlos Lopes-JúniorLuís Carlos Lopes-Júnior
Luís Carlos Lopes-Júnior
VFVictor Ferraz
Victor Ferraz
RLRegina Aparecida Garcia Lima
Regina Aparecida Garcia Lima
SSSara Isabel Pimentel Carvalho Schuab
Sara Isabel Pimentel Carvalho Schuab
RPRaphael Manhaes Pessanha
Raphael Manhaes Pessanha
SBSilvia Regina Bertolini
Silvia Regina Bertolini
Objective: To identify and map the available evidence on the implementation of public health policies directed at individuals with rare diseases, and to compare the implementation of these health policies between Brazil and other countries. Method: A scoping review guided by the PRISMA-ScR and JBI checklists. The search for articles was conducted in eight electronic databases, MEDLINE/Pubmed, Embase, Cochrane Library, Web of Science, Scopus, CINAHL, PsycINFO, and LILACS, using controlled descriptors, synonyms, and keywords combined with Boolean operators. All steps of this review were independently conducted by two researchers. The selected studies were classified by evidence hierarchy, and a generic quantitative tool was used for the assessment of the studies. Results: A total of 473 studies were identified, of which 13 which met all the inclusion criteria were selected and analyzed. Of these studies, 61.5% (n = 8) had final scores equal to or greater than 70%, i.e., they were classified by this tool as being well-reported. The comparative analysis of international rare diseases demonstrates that public authorities’ priorities and recommendations regarding this topic also permeate and apply to the Brazilian context. Conclusions: The evaluation and monitoring of public policies directed at rare disease patients are urgent and necessary to improve and implement such policies with less bureaucracy and more determination for this unique population that requires timely and high-quality care.

13 February 2018 in Journal of Toxicology and Environmental Health, Part A
Verified
Journal Article
Closed access
KNKarolini Zuqui Nunes
Karolini Zuqui Nunes
MFMirian Fioresi
Mirian Fioresi
VMVinicius Bermond Marques
Vinicius Bermond Marques
DVDalton Valentim Vassallo
Dalton Valentim Vassallo
The mechanisms involved in vascular reactivity alterations promoted by copper (Cu) overload were investigated. Thoracic aorta obtained from male Wistar rats were cut into rings and exposed for 1 h to 10 µg/ml Cu. Exposure to Cu decreased the contractile responses of aortic rings to phenylephrine (PHE). Removal of endothelium and subsequent administration of N-nitro-L arginine methyl ester (L-NAME), tetrahydrobiopterin, aminoguanidine, diethyldithiocarbamic acid, catalase, or tetraethylammonium increased contractile responses. Incubation with apocinyn and tiron enhanced the sensitivity to PHE. Data demonstrated that high concentrations of Cu reduced PHE-mediated vascular reactivity which was associated with elevated production of nitric oxide (NO), which was attributed to activation of inducible NO synthase, and elevated levels of hydrogen peroxide probably related to a rise in superoxide dismutase activity and reactive oxygen species generation.

29 December 2019 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
LOLeandro F. Oliveira
Leandro F. Oliveira
LRLaís D. Rodrigues
Laís D. Rodrigues
GCGiancarlo M. Cardillo
Giancarlo M. Cardillo
MNMariana B. Nejm
Mariana B. Nejm
MGMarcia Guimarães-Marques
Marcia Guimarães-Marques
FSFulvio A. Scorza
Fulvio A. Scorza

19 April 2024 in Medicine
Verified
Journal Article
Open access
KNKarolini Zuqui Nunes
Karolini Zuqui Nunes
WGWESLEY ROCHA GRIPPA
WESLEY ROCHA GRIPPA
ABAndressa Bolsoni-Lopes
Andressa Bolsoni-Lopes
KNKaroline Neumann
Karoline Neumann
Jonathan GrassiJonathan Grassi
Jonathan Grassi
Luís Carlos Lopes-JúniorLuís Carlos Lopes-Júnior
Luís Carlos Lopes-Júnior
Patients with cancer undergoing chemotherapy may have different cancer symptom clusters (CSC) that negatively impact their quality of life (QoL). These symptoms can sometimes arise from the disease itself or as a result of their cancer treatment. This study aimed to: examine the feasibility of longitudinal testing of CSC pattern and QoL in a sample of adult cancer patients undergoing outpatient chemotherapy; to identify the cardiovascular risk of patients with cancer undergoing outpatient chemotherapy; and to investigate the most prevalent CSC and their impact on the QoL of these patients. A longitudinal pilot study was conducted with eleven participants with a mean age of 56.09 years (range: 27–79) diagnosed with malignant neoplasm and undergoing outpatient chemotherapy treatment were evaluated during 6 cycles of chemotherapy. The CSC, cardiovascular risk, and QoL were assessed using the MSAS, FRS, and EQ-5D-3L™, respectively. Descriptive statistical and non-parametric bivariate analyses were performed. Patients who started chemotherapy treatment generally had a low to moderate cardiovascular risk and were likely to have a family history of hypertension, acute myocardial infarction, and stroke. Cardiovascular risk was found to be correlated with patient age (Rho s  = 0.64; P = .033). In addition, the results showed a reduction in the QoL scoring over the 6 chemotherapy sessions. Regarding the most prevalent CSC, 2 clusters were identified: the neuropsychological symptom cluster (difficulty concentrating-sadness-worry) and the fatigue-difficulty sleeping cluster. Between the first and sixth chemotherapy sessions, there was a decrease in the perception of “mild” severity (P = .004) and an increase in the perception of “severe” and “very severe” (P = .003) for all symptoms. Adequate attention to CSC should be the basis for the accurate planning of effective interventions to manage the symptoms experienced by cancer patients.

7 February 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AFAmanda Machado Fiorotti
Amanda Machado Fiorotti
AGAmanda Cristina Araújo Gomes
Amanda Cristina Araújo Gomes
ABAmanda Motta Bortoli
Amanda Motta Bortoli
BBBeatriz Bobbio de Brito
Beatriz Bobbio de Brito
KNKarolini Zuqui Nunes
Karolini Zuqui Nunes
ABAndressa Bolsoni-Lopes
Andressa Bolsoni-Lopes
The remission of obesity-related diseases following bariatric surgery appears to result from the reorganization of metabolic and hormonal pathways involving adipokines. This study aimed to investigate the relationship between changes in body adiposity and serum adipokine levels, as well as the association between variations in adiponectin or resistin levels and cardiometabolic risk blood biomarkers before and after Roux-en-Y gastric bypass. A longitudinal and prospective study was conducted with bariatric surgery patients. Anthropometric, body composition and blood biochemical parameters were measured before and at 2 and 6 months post-surgery. The data were analyzed using ANOVA, Pearson or Spearman correlation, and simple linear regression with a significance level of p < 0.05. Among 36 mostly female patients aged 30 to 39 years, significant reductions in body weight (−26.8%), fat mass (−50%), waist circumference (−18%) and waist-to-height ratio (−22%) were observed post-surgery. Serum adiponectin levels increased (+107%), while resistin (−12.2%), TNF-α (−35%), and PAI-1 (−11.1%) decreased. Glucose, insulin, CRP, cholesterol, LDL-c, triglycerides, and vitamin D also decreased. Waist circumference variation showed a positive correlation with PAI-1 and TNF-α and a negative correlation with adiponectin. The total fat mass showed a positive correlation with PAI-1. Adiponectin variation correlated negatively with glucose, resistin, and CRP but positively with HDL-c. Resistin showed a positive correlation with insulin and CRP. In conclusion, 6 months post-bariatric surgery, reducing abdominal adiposity had a more significant impact on serum adipokine levels than total fat mass. Adiponectin increase and resistin decrease acted as endocrine mediators driving the remission of cardiometabolic risk biomarkers in individuals with obesity following Roux-en-Y gastric bypass.